Stoppering is one of the most critical operations in prefilled syringe (PFS) manufacturing. It involves inserting and sealing the plunger stopper into the syringe barrel after the drug solution has been filled. While it may seem like a straightforward step, stoppering directly influences container closure integrity (CCI), drug stability, sterility assurance, dosing accuracy, and patient usability. A comprehensive understanding of the process, techniques, and design parameters is essential for ensuring product quality and regulatory compliance.
The Importance of Stoppering
Container Closure Integrity (CCI) and Sterility
The stopper acts as a barrier that maintains sterility throughout the product’s shelf life. If improperly seated, it can compromise the seal, allowing microbial ingress or gas exchange. This is especially critical in biologics and sensitive drug formulations where even trace contamination or oxygen exposure can degrade the product.
Headspace and Bubble Management
During stoppering, a small amount of headspace (air bubble) is often left inside the syringe. While necessary in certain cases (e.g., for preventing stopper movement during plunger actuation), excessive headspace can expand under temperature or pressure fluctuations, displacing the stopper or compromising the seal. Controlling bubble height through optimized vacuum stoppering or filling under nitrogen is vital to ensuring long-term stability and safety.
Delivery Performance and Patient Experience
The stopper must provide a balance between tight sealing and smooth delivery. Too much friction increases the break-loose force (initial force to start plunger movement), causing inconsistent dosing and discomfort for the patient. Coatings such as silicone or fluoropolymer are often applied to reduce glide resistance, but these must remain intact during stoppering to ensure performance.
Stoppering Methods
Vented Stoppering
In vented stoppering, the stopper is compressed in a tube and inserted into the syringe barrel, then allowed to expand into place.
-
Advantages: High throughput, precise stopper placement, widely used in large-scale production.
-
Limitations: Leaves air bubbles; may damage stopper coatings; less suitable for oxygen-sensitive biologics.
Vacuum Stoppering (In-line)
Here, a vacuum is applied as the stopper is inserted, reducing or eliminating headspace.
-
Advantages: Minimal bubble height; reduced oxygen exposure; better CCI for sensitive products.
-
Limitations: Requires specialized equipment and precise control; may reduce line speed.
Offline Vacuum Stoppering
Syringes are filled first and then moved into a vacuum chamber for stoppering.
-
Advantages: Can achieve near-zero headspace; excellent for biologics and oxygen-sensitive drugs.
-
Limitations: Additional handling increases contamination risk; more complex logistics; lower throughput.
Critical Parameters in Stoppering
Vacuum Level
Defines how much residual air remains inside the syringe. Stronger vacuum minimizes bubble height but must be optimized to avoid stopper misplacement.
Break-Loose and Glide Force
Measures the initial and continuous force required to move the plunger. Too high can impair usability; too low risks leakage or loss of seal integrity.
Stopper Material and Coating
Elastomer selection, compressibility, and surface coating directly impact both seal quality and delivery performance. Coating integrity must be preserved during insertion.
Insertion Speed and Alignment
Automated systems must control insertion force, angle, and speed to prevent stopper damage, coating smears, or misalignment.
Container Format
Differences between glass and polymer syringes (inner surface smoothness, dimensional tolerances) require adapted stoppering solutions.
Quality and Regulatory Considerations
Validation and Testing
-
Container Closure Integrity Testing (CCIT): Methods include vacuum decay, dye ingress, and high-voltage leak detection.
-
Stability Testing: Ensures no stopper movement or leakage under transportation stress (altitude, vibration, temperature cycling).
-
Friction and Glide Testing: Confirms usability and compliance with pharmacopeia standards.
GMP and Documentation
Since stoppering is a critical process, all parameters must be validated, monitored, and documented. Any change in stopper type, coating, or stoppering method requires change control and requalification under regulatory frameworks such as FDA 21 CFR and EU GMP Annex 1.
Best Practices for Stoppering
-
Use vacuum-assisted stoppering for oxygen-sensitive or biologic formulations.
-
Control bubble height to prevent displacement during transport or storage.
-
Select stopper materials and coatings based on compatibility with the drug formulation.
-
Validate break-loose and glide forces to ensure patient-friendly injection experience.
-
Apply robust CCIT methods to guarantee sterility throughout shelf life.
Conclusion
Stoppering in prefilled syringe manufacturing is far more than just inserting a rubber plug. It is a critical determinant of product sterility, stability, usability, and regulatory compliance. Manufacturers must carefully choose the right stoppering method, validate process parameters, and use high-precision equipment to ensure consistent outcomes.
At Zhejiang Leadtop Pharmaceutical Machinery (LTPM CHINA), we provide advanced fill-finish and stoppering systems designed for RTU syringes, vials, and cartridges. Our solutions integrate vacuum stoppering technology, robotic handling, and GMP-compliant in-process controls, enabling pharmaceutical companies to maintain the highest levels of quality assurance. Backed by a five-year warranty, our systems ensure reliable and scalable syringe manufacturing.